iPatientCare is all Set and Ready to Replace MyWay Users at No Cost. Easy Product Conversion Process and No Data Loss. MyWay resellers Welcome to join iPatientCare as Channel Partners.
Woodbridge, NJ, November 27, 2012, — According to Allscripts’ announcement, the MyWay EHR product will not be enhanced to meet Stage 2 Meaningful Use and users are being told they will need to move to a new EHR or to convert to an alternative Allscripts product starting in January 2013. There is an announcement posted at this link: http://blog.allscripts.com/2012/10/05/evolving-industry-evolving-ehrs/ . However, that is not the only option MyWay users have. iPatientCare, Inc., a pioneer in mHealth and cloud based ambulatory EHR, integrated Practice Management and Patient Portal solutions, wants to help their users migrate to the most advanced EHR in the marketplace – iPatientCare Unified System: EHR/PMS/Patient Portal.
“We will ensure that MyWay users can continue to use their existing records because we will import them into iPatientCare database at no cost and no loss of data. We also understand that the loss in productivity due to conversion from one product to another can negatively impact the practice for many months, we assure MyWay users the lowest time frame and easy process of conversion and adaptation. Based on our track record of achieving such task for many customers, we are very confident to make this an open offer”, said Udayan Mandavia, President and CEO, iPatientCare.
He further stated, “iPatientCare will not charge a license fee to any MyWay customers who sign a maintenance and support agreement before December 31, 2012. MyWay users may continue to work with their existing MyWay reseller. iPatientCare offers an excellent Channel Partner program and would be very happy to enroll existing MyWay resellers as iPatientcare Channel Partners. iPatientCare is one of the highly functional product providing easy-to-use point-and-tap interface, and hence, the learning curve will be very flat compared to many other products available in the market.”